Diagnostear ltd

General Data

supplementary funding
Reg Number
514733765
Sector
Biomed
Established
2013
No. of Employees
8
Stage
R&D
Additional Funding
1

Description

A leading ophthalmic company developing and commercializing disruptive diagnostic solutions based on tear analysis. Diagnostear has developed a test for diagnosis of Dry Eye, and is now developing a test for differential diagnosis of Red Eye

Technology

Point-of-Care Testing (POCT) of ophthalmic pathologies.

Targeted Customers

Ophthalmologists, Optometrists, Eye Clinics, Diagnostic Laboratories, Pharmaceutical Companies.

Management personnel

Shimon Gross - CEO
Amos Sommer - CTO

Contact information

Name
Shimon Gross
Phone
0523408550
Website
http://diagnostear.com
Country
Israel
Zip
7670609

Tags

BiotechnologyDiagnosticsLife SciencesMedTechOphthalmology

Classified Technologies

Biomedicine and pharmaceuticals

Winning details

Route name
Winning year

The Expedited Program
The Expedited Program
2023